Bionano Genomics- Warrants (21/08/2023) PEG Ratio

The latest PEG ratio for BNGOW is -3.9. That is below the Healthcare sector average of 2.89. Investors often review this figure alongside Bionano Genomics- Warrants (21/08/2023)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BNGOW currently prints -3.9 for PEG ratio, while the sector average sits near 2.89. That is roughly 234.8% below the sector mean. Large gaps often invite a closer look at Bionano Genomics- Warrants (21/08/2023)'s growth, margins, and balance sheet.

A PEG ratio of -3.9 for Bionano Genomics- Warrants (21/08/2023) is not 'good' or 'bad' on its own. Compare it with the peer average (2.89) and with BNGOW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BNGOW's PEG ratio (-3.9), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bionano Genomics- Warrants (21/08/2023)'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.